MedPath

Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease

Not Applicable
Recruiting
Conditions
Alzheimer's Disease
Interventions
Other: Usual care
Other: Multidimensional fragility index questionnaire RAI-Home Care
Registration Number
NCT03360552
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Brief Summary

The objective of the present study is to evaluate the effectiveness of a general practitioner (MG) management strategy guided by a multidimensional evaluation on the multidimensional score of fragility of patients with mild to moderately severe dementia, compared to those currently implemented (without the provision of such an assessment). The measurement of the respective effectiveness of the two types of care in primary care will itself be based on a multidimensional evaluation performed independently in the memory center having established the diagnosis of Alzheimer's disease. The secondary objectives are the evaluation of the impact of the strategy on the functional abilities of patients, the incidence of geriatric syndromes, cognitive functions, quality of life of the patient and the burden of the primary caregiver. The efficiency of the strategy will be assessed through a cost-effectiveness analysis. A survey of opinions will also be conducted among primary health care providers, carers and CMs on the implemented system.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
320
Inclusion Criteria
  • Patients with probable Alzheimer's disease, according to the criteria usually used in memory centers
  • Aged over 64 years with mild to moderately severe dementia syndrome
  • Volunteers for medical follow-up for a period of 20 months; Which the general practitioner attending agrees to participate in the research
Exclusion Criteria
  • Patients under 65 years old
  • presenting with early cognitive decline or severe dementia
  • Not meeting the clinical diagnostic criteria for Alzheimer's disease
  • Refusing or unable to sign informed consent to participate
  • Not voluntary for medical follow-up for a period of 20 months
  • Whose general practitioner refuses to participate in the research

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual careUsual caresupport for patients without multidimensional evaluation (RAI-CA)
the multidimensional score of fragility (RAI CA)Multidimensional fragility index questionnaire RAI-Home CareA general practitioner (MG) management strategy guided by a multidimensional evaluation (RAI-CA) on the multidimensional score of fragility (RAI-HC) of patients with mild to moderately severe dementia.
Primary Outcome Measures
NameTimeMethod
Assessment of multidimensional fragility scores20 months

The multidimensional evaluation score produced by Nurses in the home of AM patients and passed on to patients' doctors increases decision-making and patient care

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assistance Publique Hôpitaux de Marseille

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath